Aug 14 (Reuters)-
Prism Biolab Co., Ltd.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Jun 30, 2026 Jun 30, 2025 Sep 30, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 369 mln 309 mln
(+19.4 pct) (+44.0 pct)
Operating loss 829 mln loss 753 mln
Recurring loss 800 mln loss 738 mln
Net loss 845 mln loss 803 mln
EPS loss 22.90 yen loss 22.06 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Prism Biolab Co., Ltd..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=206A.T